3rd Ocular Diseases & Drug Discovery

Venue: Boston

Location: Boston, Massachusetts, United States

Event Date/Time: May 26, 2011
Report as Spam

Description

To address the continuing advances in disease therapies, as well as solving unmet needs of ocular disease drug therapies in aging individuals, GTCbio is proud to announce its 3rd Ocular Diseases & Drug Discovery Conference.
Several companies have taken the initiative in developing ocular disease therapies, with exciting new developments in kinase inhibitors. These companies include Pfizer, EyeGate, pSivida, Merck, Regeneron, Genzyme, Novartis, Ophthotech, Macusight, Neurotech, GlaxoSmithKline and many more.
To help promote the discovery of ocular disease and drug development, GTCbio is bringing together leading scientists, researchers, and experts to discuss and collaborate on the latest research and drugs available in combating and curing age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, uveitis and other eye diseases at the 3rd Ocular Diseases & Drug Discovery Conference.

Venue

Boston
One Seaport Lane
Boston
Massachusetts
United States
MORE INFO ON THIS VENUE